Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in CRDF — Cardiff Oncology, Inc.

CIK 1603466 STAMFORD, CT
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$36,900
-$2,169,720 QoQ
Shares Held
28,385
-94.4% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 104 holders
Holding Since
Dec 2021
3 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. CRDF ranks #160 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in CRDF

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $36,900 28,385
2024-12-31 $2,206,620 508,438
2021-12-31 $3,014,910 501,649